We are monitoring the impact of COVID-19 on Latin America Lung Cancer Therapeutics Market Get in touch with us for detailed analysis Know More
Share on

Latin America Lung Cancer Therapeutics Market Research Report - Segmented By Treatment Type & Country (Mexico, Brazil, Argentina, Chile & Rest of Latin America) - Industry Analysis, Size, Share, Growth, Trends & Forecasts (2022 to 2027)

Published: January, 2022
ID: 837
Pages: 138

LATAM Lung Cancer Therapeutics Market Size & Growth (2022 to 2027)

The Latin America Lung Cancer Therapeutics Market was worth USD 0.97 billion in 2022 and estimated to be growing at a CAGR of 7.29%, to reach USD 1.37 billion by 2027.

Lung Cancer is an uninhibited expansion of abnormal cells that initiates off in one or both lungs; for the maximum part in the cells that line the air units. The immediate cells don’t form into solid lung tissue but they expand rapidly and form tumors. As cancer becomes bigger and more in number, they decline the lung’s ability to deliver the bloodstream with oxygen.

Air pollution, amplified alcohol consumption, varying lifestyle, smoking, unhealthy food, and no physical activity are the factors indirectly driving the market. Governments in developing economies like the Latin America region are providing awareness among the people about cancer.

The high cost of the treatment and lack of consciousness among the people for initial recognition of cancer are detained for lung cancer therapeutics market

This research report on the Latin America Lung Cancer Therapeutics Market is segmented and sub-segmented into the following categories:

By Treatment Type:

  • Chemotherapy
    • Cisplatin
    • Taxol
    • Navelbine
    • Camptosar
    • Alimta
  • Radiotherapy
    • External Beam
    • Internal Beam
    • Systemic
  • Other Drugs
    • Abraxane
    • Avastin
    • Crizotinib
    • Docetaxel
    • Gefitinib

By Country:

  • Mexico
  • Brazil
  • Argentina
  • Chile
  • Rest of Latin America

Regionally, Mexico is dominating the Latin America region's lung cancer therapeutics market and estimated to continue its dominance over the forecast period, while Argentina is expected to witness high growth in the coming years.

Prominent companies leading in the Latin American Lung Cancer Therapeutics Market profiled in this report are Boehringer Ingelheim GmbH, Hoffman-La Roche, Pfizer Inc., GlaxoSmithKline, Eli Lilly and Company, Agennix AG, AstraZeneca plc, and Sanofi-Aventis.

1. Introduction                                                 

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                           

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                              

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                            

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                     

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                      

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 New Developments                                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                      

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                               

5. Market Segmentation                                                              

                5.1 By Treatment Type                                 

                                5.1.1 Chemotherapy                     

                                                5.1.1.1 Cisplatin

                                                5.1.1.2 Taxol      

                                                5.1.1.3 Navelbine            

                                                5.1.1.4 Camptosar          

                                                5.1.1.5 Alimta   

                                5.1.2 Radiotherapy                         

                                                5.1.2.1 External Beam   

                                                5.1.2.2 Internal Beam    

                                                5.1.2.3 Systemic              

                                5.1.3 Other Drugs                            

                                                5.1.3.1 Abraxane             

                                                5.1.3.2 Avastin 

                                                5.1.3.3 Crizotinib             

                                                5.1.3.4 Docetaxel            

                                                5.1.3.5 Gefitinib               

6. Geographical Analysis                                                              

                6.1 Introduction                                              

                6.2 Brazil                                             

                6.3 Mexico                                         

                6.4 Argentina                                    

                6.5 Rest of Latin America                                             

7. Pipeline Product Analysis                                                       

                7.1 Overview                                                    

                7.2 Pipeline Development Landscape                                                    

                7.3 Molecular Targets in the Pipeline                                                     

                7.4 Clinical Trials                                             

                                7.4.1 Failure Rate by Stage of Development, Indication, Molecule Type and Molecular Target                       

                                7.4.2 Clinical Trial Duration by Stage of Development, Indication, Molecule Type and Molecular Target                                  

                                7.4.3 Clinical Trial Size by Stage of Development, Indication, Molecule Type and Molecular Target.                               

8. Strategic Analysis                                                       

                8.1 PESTLE analysis                                         

                                8.1.1 Political                     

                                8.1.2 Economic                 

                                8.1.3 Social                         

                                8.1.4 Technological                         

                                8.1.5 Legal                          

                                8.1.6 Environmental                      

                8.2 Porter’s Five analysis                                              

                                8.2.1 Bargaining Power of Suppliers                        

                                8.2.2 Bargaining Power of Consumers                    

                                8.2.3 Threat of New Entrants                     

                                8.2.4 Threat of Substitute Products and Services               

                                8.2.5 Competitive Rivalry within the Industry                      

9. Market Leaders' Analysis                                                        

                9.1 BoehringerIngelheim GmbH                               

                                9.1.1 Overview                

                                9.1.2 Product Analysis                   

                                9.1.3 Strategic Evaluation and Operations                            

                                9.1.4 Financial analysis                  

                                9.1.5 Legal issues                            

                                9.1.6 Recent Developments                       

                                9.1.7 SWOT analysis                       

                                9.1.8 Analyst View                          

                9.2 Hoffman-La Roche                                  

                9.3 Pfizer Inc.                                    

                9.4 GlaxoSmitKline                                         

                9.5 Eli Lilly and Company                                             

                9.6 AstrazenecaPlc                                         

                9.7 Sanofi-Aventis                                          

                9.8 Agennix AG                                

10. Competitive Landscape                                                         

                10.1 Market share analysis                                          

                10.2 Merger and Acquisition Analysis                                     

                10.3 Agreements, collaborations and Joint Ventures                                       

                10.4 New Product Launches                                       

11. Expert Opinions                                                        

                11.1 Market Outlook                                     

                11.2 Investment Opportunities                                 

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                           

  1. Latin America Lung Cancer Therapeutics Market By Region, From 2022 - 2027 (USD Billion)
  2. Latin America Lung Cancer Therapeutics Market By Treatment Type, From 2022 - 2027 (USD Billion)
  3. Latin America Chemotherapy Market By Region, From 2022 - 2027 (USD Billion)
  4. Latin America Radiotherapy Market By Region, From 2022 - 2027 (USD Billion)
  5. Latin America Other Lung Cancer Therapeutic Drugs Market By Region, From 2022 - 2027 (USD Billion)
  6. Brazil Lung Cancer Therapeutics Market By Treatment Type, From 2022 - 2027 (USD Billion)
  7. Argentina Lung Cancer Therapeutics Market By Treatment Type, From 2022 - 2027 (USD Billion)
  8. Mexico Lung Cancer Therapeutics Market By Treatment Type, From 2022 - 2027 (USD Billion)
  9. Latin America Lung Cancer Chemotherapy Market By Drug Type, From 2022 - 2027 (USD Billion)
  10. Latin America Cisplatin Market By Region, From 2022 - 2027 (USD Billion)
  11. Latin America Taxol Market By Region, From 2022 - 2027 (USD Billion)
  12. Latin America Navelbine Market By Region, From 2022 - 2027 (USD Billion)
  13. Latin America Camptosar Market By Region, From 2022 - 2027 (USD Billion)
  14. Latin America Alimta Market By Region, From 2022 - 2027 (USD Billion)
  15. Brazil Lung Cancer Chemotherapy Market By Drug Type, From 2022 - 2027 (USD Billion)
  16. Argentina Lung Cancer Chemotherapy Market By Drug Type, From 2022 - 2027 (USD Billion)
  17. Mexico Lung Cancer Chemotherapy Market By Drug Type, From 2022 - 2027 (USD Billion)
  18. Latin America Lung Cancer Radiotherapy Market By Type, From 2022 - 2027 (USD Billion)
  19. Latin America External Beam Market By Region, From 2022 - 2027 (USD Billion)
  20. Latin America Internal Beam Market By Region, From 2022 - 2027 (USD Billion)
  21. Latin America Systemic Market By Region, From 2022 - 2027 (USD Billion)
  22. Brazil Lung Cancer Radiotherapy Market By Type, From 2022 - 2027 (USD Billion)
  23. Argentina Lung Cancer Radiotherapy Market By Type, From 2022 - 2027 (USD Billion)
  24. Mexico Lung Cancer Radiotherapy Market By Type, From 2022 - 2027 (USD Billion)
  25. Latin America Other Lung Cancer Therapeutic Drugs Market By Drug Type, From 2022 - 2027 (USD Billion)
  26. Latin America Abraxane Market By Region, From 2022 - 2027 (USD Billion)
  27. Latin America Avastin Market By Region, From 2022 - 2027 (USD Billion)
  28. Latin America Crizotinib Market By Region, From 2022 - 2027 (USD Billion)
  29. Latin America Docetaxel Market By Region, From 2022 - 2027 (USD Billion)
  30. Latin America Gefitinib Market By Region, From 2022 - 2027 (USD Billion)
  31. Brazil Other Lung Cancer Therapeutic Drugs Market By Drug Type, From 2022 - 2027 (USD Billion)
  32. Argentina Other Lung Cancer Therapeutic Drugs Market By Drug Type, From 2022 - 2027 (USD Billion)
  33. Mexico Other Lung Cancer Therapeutic Drugs Market By Drug Type, From 2022 - 2027 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

2875


pdf excel
$

3220


pdf excel powerbi
$

4600


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2875

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample